Pretax income is the income that a company earns before paying income taxes. WAVE Life Sciences's pretax income for the
three
months ended in Dec. 2023 was $-16.3 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-58.2 Mil.
WAVE Life Sciences's pretax margin was -55.95%.
During the past 11 years, WAVE Life Sciences's highest Pretax Margin was -51.36%. The lowest was -12602.63%. And the median was -1211.52%.
WAVE Life Sciences Pre-Tax Income Historical Data
The historical data trend for WAVE Life Sciences's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of WAVE Life Sciences's Pre-Tax Income
For the Biotechnology subindustry, WAVE Life Sciences's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
WAVE Life Sciences's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, WAVE Life Sciences's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where WAVE Life Sciences's Pre-Tax Income falls into.
WAVE Life Sciences Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
WAVE Life Sciences's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-58.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAVE Life Sciences (NAS:WVE) Pre-Tax Income Explanation
WAVE Life Sciences's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 11 years, WAVE Life Sciences's highest Pretax Margin was -51.36%. The lowest was -12602.63%. And the median was -1211.52%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAVE Life Sciences Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of WAVE Life Sciences's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
WAVE Life Sciences (WAVE Life Sciences) Business Description
WAVE Life Sciences Ltd is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company's proprietary discovery and drug development platform that enables the precise design, optimization, and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WVE has been successfully added to your 